ESR1 and breast carcinoma: For example, interactions of bone marrow mesenchymal stem cells (MSCs) with metastasized ER+ (estrogen receptor-positive) breast cancer cells in bone marrow led to metabolic shift and dormancy of cancer cells and resistance to endocrine therapies [41].